首頁
Crescent Enterprises

7月 2026Crescent Enterprises的市場佔有率分析

Crescent Enterprises recognises the importance of protecting the privacy of personal information of our users of the Site. The Site will record and track the

商業服務和消費者服務 > 商業服務

域名crescententerprises.com

成立年份2015

僱員1001 - 5000

年度營收$2M - $5M

Crescent Enterprises

Crescent Enterprises（包含公司地區）

crescententerprises.com

查看更多網站流量與參與度資訊

Crescent Enterprises截至 7月 2026 的總收入為 2M - 5M

Crescent Enterprises 熱門網域產生的總收入

Crescent Enterprises 熱門網域 3 年內的總收入

Crescent Enterprises 熱門網域的總收入

crescententerprises.com2M - 5M

透過銷售情報查看更多內容

Crescent Enterprises的熱門網域總造訪量

了解Crescent Enterprises市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

crescententerprises.com3.5K

透過銷售情報查看更多內容

Crescent Enterprises的熱門網域平均造訪時長

分析Crescent Enterprises參與度指標。

過去 3 個月平均造訪時長

子公司細目

crescententerprises.com00:00:54

透過銷售情報查看更多內容

Crescent Enterprises的熱門網域平均頁面瀏覽量

了解Crescent Enterprises如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

crescententerprises.com1.98

透過銷售情報查看更多內容

Crescent Enterprises按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術Crescent Enterprises

这些是Crescent Enterprises顶级域名使用的行业网站技术

小工具 (7)

Twemoji

轉換與分析 (3)

Google Analytics

社群 (3)

Instagram

付費廣告 (2)

PubMatic

更多技術

8

檢視所有

新聞與訊號來自Crescent Enterprises

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Crescent Group receives award Impact Seal, Gold Tier.Crescent Enterprises, the leading multinational diversified business headquartered in the UAE, has received the Impact Seal, Gold Tier from Majra, the UAE's national corporate social responsibility (CSR) fund, as part of the 2025 to 2027 Impact Seal cycle, in recognition of its sustained commitment to responsible business and measurable impact.

新聞Crescent Group invested into CrossBridge Bio $10M in Seed on Jul 1st '24.CE-Ventures co-led CrossBridge Bio's USD 10 million initial financing round announced in November 2024, backing the company at an important stage in its development.

新聞Crescent Group invests into Thinkbioscience $55M in Series A.CE-Ventures, the corporate venture capital platform of UAE-headquartered Crescent Enterprises, has invested in an oversubscribed $55 million Series A funding round for Think Bioscience, a US-based biotech company focused on developing treatments for historically challenging drug targets, including Noonan syndrome.